Literature DB >> 12468411

Hypothalamic regulation of energy homeostasis.

Amanda Sainsbury1, Gregory J Cooney, Herbert Herzog.   

Abstract

The co-ordinated regulation of food intake and energy expenditure takes place in the hypothalamic regions of the brain. Current understanding of the systems involved in this regulation suggests that, in the hypothalamus, there are two major groups of neuropeptides involved in orexigenic and anorexic processes. The orexigenic neuropeptides are neuropeptide Y (NPY) and agouti-related peptide (AgRP) and the anorexic neuropeptides are alpha-melanocyte-stimulating hormone (alpha-MSH) and cocaine and amphetamine-related transcript (CART). Theneurons expressing these neuropeptides interact with each other and with signals from the periphery (such as leptin, insulin, ghrelin and glucocorticoids) to regulate feeding behaviour, energy expenditure and various endocrine axes. Although direct evidence is limited, there are examples of genetic obesity in humans which suggest that the balance between orexigenic and anorexic pathways in the hypothalamus is also pivotally important in the maintenance of energy homeostasis in humans.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12468411     DOI: 10.1053/beem.2002.0230

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  24 in total

Review 1.  Gut hormones and leptin: impact on energy control and changes after bariatric surgery--what the future holds.

Authors:  Konstantinos Michalakis; Carel le Roux
Journal:  Obes Surg       Date:  2012-10       Impact factor: 4.129

2.  Synergistic effects of genetic beta cell dysfunction and maternal glucose intolerance on offspring metabolic phenotype in mice.

Authors:  S M Lau; S Lin; R A Stokes; K Cheng; P A Baldock; R F Enriquez; M McLean; N W Cheung; A Sainsbury; F J Gonzalez; H Herzog; J E Gunton
Journal:  Diabetologia       Date:  2010-12-22       Impact factor: 10.122

3.  Impact of exercise and dietary fatty acid composition from a high-fat diet on markers of hunger and satiety.

Authors:  J A Cooper; A C Watras; C M Paton; F H Wegner; A K Adams; D A Schoeller
Journal:  Appetite       Date:  2010-10-28       Impact factor: 3.868

4.  Non-referenced genome assembly from epigenomic short-read data.

Authors:  Antony Kaspi; Mark Ziemann; Samuel T Keating; Ishant Khurana; Timothy Connor; Briana Spolding; Adrian Cooper; Ross Lazarus; Ken Walder; Paul Zimmet; Assam El-Osta
Journal:  Epigenetics       Date:  2014-10       Impact factor: 4.528

5.  Influence of renovascular hypertension on the distribution of vasoactive intestinal peptide in the stomach and heart of rats.

Authors:  Irena Kasacka; Żaneta Piotrowska; Izabela Janiuk
Journal:  Exp Biol Med (Maywood)       Date:  2015-05-19

6.  The Way to the Liver Is Through the Pituitary Gland.

Authors:  Ashraf A Ashhab; Jeffrey Albrecht; Jose D Debes
Journal:  Am J Gastroenterol       Date:  2018-01       Impact factor: 10.864

7.  Leptin, its implication in physical exercise and training: a short review.

Authors:  Anissa Bouassida; Dalenda Zalleg; Semi Bouassida; Monia Zaouali; Youssef Feki; Abdelkarim Zbidi; Zouhair Tabka
Journal:  J Sports Sci Med       Date:  2006-06-01       Impact factor: 2.988

Review 8.  Sexual dimorphism in body fat distribution and risk for cardiovascular diseases.

Authors:  Thekkethil P Nedungadi; Deborah J Clegg
Journal:  J Cardiovasc Transl Res       Date:  2009-04-23       Impact factor: 4.132

9.  Decreased immunoreactivity of the melanocortin neuropeptide alpha-melanocyte-stimulating hormone (alpha-MSH) after chronic ethanol exposure in Sprague-Dawley rats.

Authors:  Montserrat Navarro; Inmaculada Cubero; Darin J Knapp; George R Breese; Todd E Thiele
Journal:  Alcohol Clin Exp Res       Date:  2007-12-21       Impact factor: 3.455

10.  Pre- and post- prandial appetite hormone levels in normal weight and severely obese women.

Authors:  Joseph J Carlson; Amy A Turpin; Gail Wiebke; Steven C Hunt; Ted D Adams
Journal:  Nutr Metab (Lond)       Date:  2009-08-11       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.